Dariusz Szczygieł

Dariusz Szczygieł

Auto-generated profile, based on publicly available information

Dariusz Szczygieł

Department of Biophysics and Cancer Biology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387 Krakow, Poland

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2024 in Molecular Imaging and Biology
Verified
Journal Article
Open access
PDF file
MSMałgorzata Szczygieł
Małgorzata Szczygieł
BKBarbara Kalinowska
Barbara Kalinowska
DSDariusz Szczygieł
Dariusz Szczygieł
MKMartyna Krzykawska-Serda
Martyna Krzykawska-Serda
LFLeszek Fiedor
Leszek Fiedor
MEMartyna Elas
Martyna Elas
Purpose: Molecular oxygen, besides a photosensitizer and light of appropriate wavelength, is one of the three factors necessary for photodynamic therapy (PDT). In tumor tissue, PDT leads to the killing of tumor cells, destruction of endothelial cells and vasculature collapse, and the induction of strong immune responses. All these effects may influence the oxygenation levels, but it is the vasculature changes that have the main impact on pO2. The purpose of our study was to monitor changes in tumor oxygenation after PDT and explore its significance for predicting long-term treatment response. Procedures: Electron paramagnetic resonance (EPR) spectroscopy enables direct, quantitative, and sequential measurements of partial pressure of oxygen (pO2) in the same animal. The levels of chlorophyll derived photosensitizers in tumor tissue were determined by transdermal emission measurements. Results: The noninvasive monitoring of pO2 in the tumor tissue after PDT showed that the higher ΔpO2 (pO2 after PDT minus pO2 before PDT), the greater the inhibition of tumor growth. ΔpO2 also correlated with higher levels of the photosensitizers in the tumor and with the occurrence of a severe edema/erythema after PDT. Conclusion: Monitoring of PDT-induced changes in tumor oxygenation is a valuable prognostic factor and could be also used to identify potentially resistant tumors, which is important in predicting long-term treatment response.

23 November 2024 in Cancers
Verified
Journal Article
Open access
PDF file
EKEwa Kowolik
Ewa Kowolik
DSDariusz Szczygieł
Dariusz Szczygieł
MSMałgorzata Szczygieł
Małgorzata Szczygieł
ADAgnieszka Drzał
Agnieszka Drzał
KVKalyani Vemuri Kalyani Vemuri
Kalyani Vemuri Kalyani Vemuri
MEMartyna Elas
Martyna Elas
Background: Glioblastoma multiforme (GBM) is the most common highly aggressive, primary malignant brain tumor in adults. Current experimental strategies include photodynamic therapy (PDT) and new drug delivery technologies such as nanoparticles, which could play a key role in the treatment, diagnosis, and imaging of brain tumors. Objectives: The purpose of this study was to test the efficacy of PDT using AGuIX-TPP, a polysiloxane-based nanoparticle (AGuIX) that contains TPP (5,10,15,20-tetraphenyl-21H,23H-porphine), in biological models of glioblastoma multiforme and to investigate the vascular mechanisms of action at multiple complexity levels. Methods: PDT effects were studied in monolayer and spheroid cell culture, as well as tumors in chicken chorioallantoic membranes (CAMs) and in mice were studied. Results: Treatment was effective in both endothelial ECRF and glioma U87 cells, as well as in the inhibition of growth of the glioma spheroids. PDT using AGuIX-TPP inhibited U87 tumors growing in CAM and destroyed their vascularization. The U87 tumors were also grown in nude mice. Their vascular network, as well as oxygen partial pressure, were assessed using ultrasound and EPR oximetry. The treatment damaged tumor vessels and slightly decreased oxygen levels. Conclusions: PDT with AGuIX-TPP was effective against glioma cells, spheroids, and tumors; however, in mice, its efficacy appeared to be strongly related to the presence of blood vessels in the tumor before the treatment.

1 December 2004 in Nitric Oxide
Verified
Journal Article
Closed access
DSDariusz Szczygiel
Dariusz Szczygiel
JPJolanta Pawlus
Jolanta Pawlus
Przemysław Mieszko PłonkaPrzemysław Mieszko Płonka
Przemysław Mieszko Płonka
MEMartyna Elas
Martyna Elas
MSMałgorzata Szczygieł
Małgorzata Szczygieł
SLStanislaw J. Lukiewicz
Stanislaw J. Lukiewicz

Verified
Journal Article
Open access
PDF file
DSDariusz Szczygieł
Dariusz Szczygieł
MSMałgorzata Szczygieł
Małgorzata Szczygieł
AŁAnna Łaś
Anna Łaś
MEMartyna Elas
Martyna Elas
RZRoxana Zuziak
Roxana Zuziak
Przemysław Mieszko PłonkaPrzemysław Mieszko Płonka
Przemysław Mieszko Płonka
Animal tumors serve as reasonable models for human cancers. Both human and animal tumors often reveal triplet EPR signals of nitrosylhemoglobin (HbNO) as an effect of nitric oxide formation in tumor tissue, where NO is complexed by Hb. In search of factors determining the appearance of nitrosylhemoglobin (HbNO) in solid tumors, we compared the intensities of electron paramagnetic resonance (EPR) signals of various iron–nitrosyl complexes detectable in tumor tissues, in the presence and absence of excess exogenous iron(II) and diethyldithiocarbamate (DETC). Three types of murine tumors, namely, L5178Y lymphoma, amelanotic Cloudman S91 melanoma, and Ehrlich carcinoma (EC) growing in DBA/2 or Swiss mice, were used. The results were analyzed in the context of vascularization determined histochemically using antibodies to CD31. Strong HbNO EPR signals were found in melanoma, i.e., in the tumor with a vast amount of a hemorrhagic necrosis core. Strong Fe(DETC)2NO signals could be induced in poorly vascularized EC. In L5178Y, there was a correlation between both types of signals, and in addition, Fe(RS)2(NO)2 signals of non-heme iron–nitrosyl complexes could be detected. We postulate that HbNO EPR signals appear during active destruction of well-vascularized tumor tissue due to hemorrhagic necrosis. The presence of iron–nitrosyl complexes in tumor tissue is biologically meaningful and defines the evolution of complicated tumor–host interactions.

Verified
Journal Article
Open access
PDF file
JSJustyna Sopel
Justyna Sopel
KSKatarzyna Sarad
Katarzyna Sarad
AKAnna Kozinska
Anna Kozinska
KMKrystian Mokrzyński
Krystian Mokrzyński
DSDariusz Szczygieł
Dariusz Szczygieł
MEMartyna Elas
Martyna Elas
Premelanosomal protein (Pmel, also known as Pmel17) is the major component of melanosomal fibrils and plays a key role in melanin polymerization, making it an important factor in melanogenesis. We investigated how the absence of Pmel affects the properties of B16F10 melanoma cells. Pmel-knockout B16F10 cells were generated using CRISPR/Cas9-mediated genome editing. A viability assay revealed no significant differences between wild-type (WT) and Pmel-knockout (KO) sublines; however, melanosome maturation was impaired. In Pmel KO cells, the cell cycle was disrupted, and higher levels of reactive oxygen species (ROS) were observed compared with WT cells. Moreover, the migration capacity and tube formation of melanoma cells were increased. Tumors derived from Pmel KO cells exhibited unchanged growth kinetics but reduced melanin content, along with enhanced vascularization and oxygenation. Thus, knockout of the Pmel17 gene in melanoma cells alters pigmentation, vascularization, and oxygenation of tumors. These parameters are crucial for both tumor progression and therapeutic response.